The Impact of Centers for Medicare & Medicaid Services SEP-1 Core Measure Implementation on Antibacterial Utilization: A Retrospective Multicenter Longitudinal Cohort Study With Interrupted Time-Series Analysis
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Background: The impact of the US Centers for Medicare & Medicaid Services (CMS) Severe Sepsis and Septic Shock: Management Bundle (SEP-1) core measure on overall antibacterial utilization is unknown. Methods: We performed a retrospective multicenter longitudinal cohort study with interrupted time–series analysis to determine the impact of SEP-1 implementation on antibacterial utilization and patient outcomes. All adult patients admitted to 26 hospitals between 1 October 2014 and 30 September 2015 (SEP-1 preparation period) and between 1 November 2015 and 31 October 2016 (SEP-1 implementation period) were evaluated for inclusion. The primary outcome was total antibacterial utilization, measured as days of therapy (DOT) per 1000 patient-days. Results: The study cohort included 701 055 eligible patient admissions and 4.2 million patient-days. Overall antibacterial utilization increased 2% each month during SEP-1 preparation (relative rate [RR], 1.02 per month [95% confidence interval {CI}, 1.00–1.04]; P = .02). Cumulatively, the mean monthly DOT per 1000 patient-days increased 24.4% (95% CI, 18.0%–38.8%) over the entire study period (October 2014–October 2016). The rate of sepsis diagnosis/1000 patients increased 2% each month during SEP-1 preparation (RR, 1.02 per month [95% CI, 1.00–1.04]; P = .04). The rate of all-cause mortality rate per 1000 patients decreased during the study period (RR for SEP-1 preparation, 0.95 [95% CI, .92–.98; P = .001]; RR for SEP-1 implementation, .98 [.97–1.00; P = .01]). Cumulatively, the monthly mean all-cause mortality rate/1000 patients declined 38.5% (95% CI, 25.9%–48.0%) over the study period. Conclusions: Announcement and implementation of the CMS SEP-1 process measure was associated with increased diagnosis of sepsis and antibacterial utilization and decreased mortality rate among hospitalized patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several studies examining the period shortly before and after SEP-1 was introduced in 2015 demonstrated significant increases in broad-spectrum and total antibiotic use in US hospitals without corresponding decreases in sepsis-associated mortality.”
From Trends in empiric broad-Spectrum antibiotic use for suspected community-onset Sepsis in US hospitals (2024) · cites this paper as [21]
Citations
Cites
Early goal-directed therapy in the treatment of severe sepsis and septic shock
Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E., & Tomlanovich, M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010307 · Cited by 10,743
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
The epidemiology of sepsis in the United States from 1979 through 2000
Martin, G. S., Mannino, D. M., Eaton, S., & Moss, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022139 · Cited by 5,841
An Introduction to the Bootstrap.
Buckland, S. T., Efron, B., & Tibshirani, R. J. (1994) · Biometrics · doi:10.2307/2532810 · Cited by 3,103
Time to treatment and mortality during mandated emergency care for sepsis.
Seymour, C. W., Gesten, F., Prescott, H. C., Friedrich, M. E., Iwashyna, T. J., Phillips, G. S., Lemeshow, S., Osborn, T., Terry, K. M., & Levy, M. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703058 · Cited by 2,225
Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014.
Rhee, C., Dantes, R., Epstein, L., Murphy, D. J., Seymour, C. W., Iwashyna, T. J., Kadri, S. S., Angus, D. C., Danner, R. L., Fiore, A. E., et al. (2017) · JAMA · doi:10.1001/jama.2017.13836 · Cited by 1,884
Ferrer, R., Martin-Loeches, I., Phillips, G., Osborn, T. M., Townsend, S., Dellinger, R. P., Artigas, A., Schorr, C., & Levy, M. M. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000330 · Cited by 1,480
The timing of early antibiotics and hospital mortality in sepsis.
Liu, V. X., Fielding-Singh, V., Greene, J. D., Baker, J. M., Iwashyna, T. J., Bhattacharya, J., & Escobar, G. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201609-1848oc · Cited by 1,006
A combined comorbidity score predicted mortality in elderly patients better than existing scores
Gagne, J. J., Glynn, R. J., Avorn, J., Levin, R., & Schneeweiss, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.10.004 · Cited by 995
Houck, P. M., Bratzler, D. W., Nsa, W., Ma, A., & Bartlett, J. G. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.6.637 · Cited by 796
Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007
Lagu, T., Rothberg, M. B., Shieh, M.-S., Pekow, P. S., Steingrub, J. S., & Lindenauer, P. K. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e318232db65 · Cited by 679
Surviving Sepsis Campaign: Association Between Performance Metrics and Outcomes in a 7.5-Year Study
Levy, M. M., Rhodes, A., Phillips, G. S., Townsend, S. R., Schorr, C. A., Beale, R., Osborn, T., Lemeshow, S., Chiche, J.-D., Artigas, A., et al. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000000723 · Cited by 566
(2012) · PsycEXTRA Dataset · doi:10.1037/e582072012-001 · Cited by 479
Regulatory Mandates for Sepsis Care — Reasons for Caution
Rhee, C., Gohil, S., & Klompas, M. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1400276 · Cited by 231
Hranjec, T., Rosenberger, L. H., Swenson, B., Metzger, R., Flohr, T. R., Politano, A. D., Riccio, L. M., Popovsky, K. A., & Sawyer, R. G. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70151-2 · Cited by 231
Rhee, C., Chiotos, K., Cosgrove, S. E., Heil, E. L., Kadri, S. S., Kalil, A. C., Gilbert, D. N., Masur, H., Septimus, E. J., Sweeney, D. A., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa059 · Cited by 191
IDSA Sepsis Task Force, Kalil, A. C., Gilbert, D. N., Winslow, D. L., Masur, H., & Klompas, M. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix997 · Cited by 177
Baghdadi, J. D., Brook, R. H., Uslan, D. Z., Needleman, J., Bell, D. S., Cunningham, W. E., & Wong, M. D. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0183 · Cited by 124
Pepper, D. J., Jaswal, D., Sun, J., Welsh, J., Natanson, C., & Eichacker, P. Q. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2947 · Cited by 79
Polgreen, P. M., Chen, Y. Y., Cavanaugh, J. E., Ward, M., Coffman, S., Hornick, D. B., Diekema, D. J., & Herwaldt, L. A. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/512174 · Cited by 71
Development of an Electronic Definition for De-escalation of Antibiotics in Hospitalized Patients
Moehring, R. W., Ashley, E. S. D., Davis, A. E., Dyer, A., Parish, A., Ren, X., Lokhnygina, Y. V., Hicks, L. A., Srinivasan, A., & Anderson, D. J. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa932 · Cited by 45
Self-citationHiensch, R., Poeran, J., Saunders-Hao, P., Adams, V., Powell, C. A., Glasser, A., Mazumdar, M., & Patel, G. (2017) · American Journal of Infection Control · doi:10.1016/j.ajic.2017.04.005 · Cited by 44
Nicks, B. A., Manthey, D. E., & Fitch, M. T. (2009) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2008.00320.x · Cited by 42
Impact of SEP-1 on broad-spectrum combination antibiotic therapy in the emergency department
Miller, J., Hall, B., Wilson, K., & Cobian, J. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2019.12.045 · Cited by 13
Townsend, S. R., Rivers, E. P., & Duseja, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa458 · Cited by 6
Cited by
Trends in empiric broad-Spectrum antibiotic use for suspected community-onset Sepsis in US hospitals
Rhee, C., Chen, T., Kadri, S. S., Lawandi, A., Yek, C., Walker, M., Warner, S., Fram, D., Chen, H.-C., Shappell, C. N., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.18923 · Cited by 58
Ford, J. S., Morrison, J. C., Kyaw, M., Hewlett, M. M., Tahir, P., Jain, S., Nemati, S., Malhotra, A., & Wardi, G. (2025) · Annals of Internal Medicine · doi:10.7326/annals-24-02426 · Cited by 44
“Anderson and colleagues performed a multi-center ( n ¼ 10) before – after unadjusted subanalysis of patients with suspected sepsis ( n ¼ 31 014) and found no difference in mortality between pre – SEP-1 and post – SEP-1 implementation periods (51).”
Rhee, C., Strich, J. R., Chiotos, K., Classen, D. C., Cosgrove, S. E., Greeno, R., Heil, E. L., Kadri, S. S., Kalil, A. C., Gilbert, D. N., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciad447 · Cited by 40
The Importance of Shifting Sepsis Quality Measures From Processes to Outcomes
Klompas, M., Rhee, C., & Singer, M. (2023) · JAMA · doi:10.1001/jama.2023.0340 · Cited by 29
Moehring, R. W., Yarrington, M. E., Warren, B. G., Lokhnygina, Y., Atkinson, E., Bankston, A., Collucio, J., David, M. Z., Davis, A. E., Davis, J., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciac787 · Cited by 27
Self-citation
Metadata
- Authors
- Anderson, D. J., Moehring, R. W., Parish, A., David, M. Z., Hsueh, K., Cressman, L., Tolomeo, P., Habrock-Bach, T., Hill, C. L., Ryan, M., O’Brien, C., Lokhnygina, Y., & Dodds Ashley, E.
- Affiliations
- Duke University (US)
- University of Pennsylvania (US)
- Washington University in St. Louis (US)
- Duke Medical Center (US)
- Duke Center for Antimicrobial Stewardship and Infection Prevention , Durham, North Carolina , USA
- Corresponding author
- Anderson, Deverick J
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-11-05
- Volume
- 75
- Issue
- 3
- Pages
- 503-511
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W3208106284
- Cited by
- 19
- References
- 28
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 3 · 2023: 6 · 2022: 3
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention (U54CK000483)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- days of therapy, sepsis diagnosis, all-cause mortality, quality metrics, process indicators, antimicrobial stewardship, hospital quality improvement, Medicare reimbursement policy
- MeSH terms
- Adult, Aged, Anti-Bacterial Agents, Medicare, Humans, Longitudinal Studies, Medicaid, Retrospective Studies, United States, Cohort Studies, Sepsis, Patient Care Bundles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.